Carna Biosciences, Inc. and Enamine Ltd. jointly announced the signing of a
collaboration agreement to cooperate on discovery and development of lead compounds
against targeted kinase. Carna Biosciences has succeeded in development of assay
systems of more than 160 kinases utilizing its proprietary technologies and
know-how on gene cloning, active protein expression, purification and screening.